Fake diabetes, multivitamin medicines worth Rs 55 lakh for sale in Delhi, Haryana seized in Himachal Pradesh’s Baddi

Solan : Exposing yet another alleged laxity of the officers of the drug control department, a spurious drugs consignment having costing Rs 55 lakh was seized by a team of drug officials from a transport company vehicle and a pharmaceutical unit premises at Baddi on Sunday.

State Drugs Controller Navneet Marwaha confirmed that a transport godown of RS roadline located at Sai road in Baddi was raided where spurious drugs worth Rs 55 lakh of Sikkim-based Mankind and Intas Pharma pertaining to sugar and multivitamin tablets have been recovered. The said company did not have the license to manufacture these drugs and it had manufactured them in the name of the two companies.

Following this seizure, the manufacturing unit M/s Magnatek enterprise, where the drugs had been manufactured at Baddi was also raided and a huge stock of tablets and scrap were recovered by the team.

Raids were conducted throughout the night. The manufacturing premises of Magnatek enterprise have been sealed while the accused manufacture is absconding.

The vehicle of the transport company was seized in which medicines were being transported by the company. It was found that the firm had sold huge stock of spurious drugs in the market and department proceedings are under investigation to recover all material from the market informed Marwaha.

Drug controller Delhi has also been informed to seize the stock from a Central Delhi based wholesale trader whose bill was recovered from the transport company. The drugs were bound for Delhi and Haryana.

Involvement of other accused in the case is under investigation informed the officials.

Related Posts

  • Pharma
  • July 24, 2025
  • 354 views
Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

Natco Pharma shares slipped 2.5% to Rs 1,009 apiece on the BSE in Thursday’s trade after the company announced its plan to acquire a 35.75% stake in South Africa-based Adcock…

  • Pharma
  • July 22, 2025
  • 372 views
DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

The Directorate General of Foreign Trade ( DGFT ) has notified an extension in the deadline for submitting applications for the export of Pharma Grade Sugar. This was communicated through Trade Notice…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra